Page last updated: 2024-08-21

thiazoles and Nycturia

thiazoles has been researched along with Nycturia in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (55.56)24.3611
2020's4 (44.44)2.80

Authors

AuthorsStudies
Delfino, K; Dynda, D; El-Zawahry, A; McVary, KT; Petrossian, RA1
Gibson, W; Makhani, A; Thake, M1
Abreu-Mendes, P; Cruz, F; Martins-Silva, C1
Furuhata, M; Hosaka, K; Ishizuka, O; Minagawa, T; Nakagawa, T; Ogawa, T; Saito, T; Suzuki, T1
Hodgkinson, L1
Chapple, C; Gacci, M; Gravas, S; Kaplan, SA; McVary, KT; Moncada, I; Morgia, G; Russo, GI; Sebastianelli, A; Serni, S1
Amarenco, G; Chapple, CR; Everaert, K; Liehne, J; López Aramburu, MA; Lucas, M; Ridder, A; Snijder, R; Vik, V; Yamaguchi, O1
Dmochowski, R; Kaufman, M; Osborn, D; Reynolds, WS; Suarez, O1
Arber, M; Fleetwood, K; Freemantle, N; Ginsberg, DA; Glanville, J; Khalaf, K; Loveman, C; McCool, R; Ni, Q1

Reviews

4 review(s) available for thiazoles and Nycturia

ArticleYear
Mirabegron in the Treatment of Overactive Bladder: Safety and Efficacy in the Very Elderly Patient.
    Clinical interventions in aging, 2020, Volume: 15

    Topics: Acetanilides; Age Factors; Aged; Aged, 80 and over; Female; Humans; Lower Urinary Tract Symptoms; Nocturia; Patient Safety; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urological Agents

2020
Treatment of neurogenic lower urinary tract symptoms: main contributions from 2018 and 2019.
    Current opinion in urology, 2020, Volume: 30, Issue:4

    Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Botulinum Toxins, Type A; Humans; Lower Urinary Tract Symptoms; Muscarinic Antagonists; Nocturia; Thiazoles; Urinary Bladder, Neurogenic; Urological Agents

2020
Systematic review and meta-analysis on the efficacy and tolerability of mirabegron for the treatment of storage lower urinary tract symptoms/overactive bladder: Comparison with placebo and tolterodine.
    International journal of urology : official journal of the Japanese Urological Association, 2018, Volume: 25, Issue:3

    Topics: Acetanilides; Humans; Lower Urinary Tract Symptoms; Nocturia; Randomized Controlled Trials as Topic; Thiazoles; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents

2018
Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparison.
    BMJ open, 2016, Feb-23, Volume: 6, Issue:2

    Topics: Acetanilides; Botulinum Toxins, Type A; Humans; Nocturia; Thiazoles; Urinary Bladder, Overactive; Urinary Incontinence; Urination; Urological Agents

2016

Trials

2 trial(s) available for thiazoles and Nycturia

ArticleYear
Effect of oxybutynin patch versus mirabegron on nocturia-related quality of life in female overactive bladder patients: A multicenter randomized trial.
    International journal of urology : official journal of the Japanese Urological Association, 2021, Volume: 28, Issue:9

    Topics: Acetanilides; Double-Blind Method; Female; Humans; Mandelic Acids; Nocturia; Quality of Life; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive

2021
A proof-of-concept study: mirabegron, a new therapy for overactive bladder.
    Neurourology and urodynamics, 2013, Volume: 32, Issue:8

    Topics: Acetanilides; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Nocturia; Quality of Life; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urination; Urological Agents

2013

Other Studies

3 other study(ies) available for thiazoles and Nycturia

ArticleYear
Mirabegron improves sleep measures, nocturia, and lower urinary tract symptoms in those with urinary symptoms associated with disordered sleep.
    The Canadian journal of urology, 2020, Volume: 27, Issue:1

    Topics: Acetanilides; Aged; Female; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Nocturia; Prospective Studies; Sleep; Sleep Wake Disorders; Thiazoles; Treatment Outcome

2020
American Urological Association (AUA) - 112th Annual Meeting (May 12-16, 2017 - Boston, Massachusetts, USA).
    Drugs of today (Barcelona, Spain : 1998), 2017, Volume: 53, Issue:6

    Topics: Acetanilides; Administration, Intranasal; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Clinical Trials, Phase III as Topic; Deamino Arginine Vasopressin; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Humans; Hydrogels; Mitomycin; Multicenter Studies as Topic; Nocturia; Randomized Controlled Trials as Topic; Solifenacin Succinate; Thiazoles; United States; Urinary Bladder Neoplasms; Urinary Bladder, Overactive; Urology

2017
Mirabegron for male lower urinary tract symptoms.
    Current urology reports, 2013, Volume: 14, Issue:6

    Topics: 5-alpha Reductase Inhibitors; Acetanilides; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Humans; Lower Urinary Tract Symptoms; Male; Nocturia; Prostatic Hyperplasia; Prostatism; Thiazoles; Urinary Bladder, Overactive; Urological Agents

2013